-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Iterum Therapeutics plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q3 2025.
- Iterum Therapeutics plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 45.8M shares, a 129% increase year-over-year.
- Iterum Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 19.7M shares, a 52% increase from 2023.
- Iterum Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 13M shares, a 5.93% increase from 2022.
- Iterum Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 12.2M shares, a 12.4% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)